Skip to main content

Advertisement

ADVERTISEMENT

Volume 27 - Issue 2 - February, 2015

Feature

Original Contribution
02/01/2015

Divya Ratan Verma, MD, MS1*;  Muhammad F. Khan, MD1*;  Anwar Tandar, MD1;  Namakkal S. Rajasekaran, PhD1,2; Ren√©e Neuharth, BS1;  Amit N. Patel, MD, MS3;  Joseph B. Muhlestein, MD1,4;  Rodney S. Badger, MD1

 
Divya Ratan Verma, MD, MS1*;  Muhamma...
We sought to compare nickel elution properties of contemporary interatrial shunt closure devices in vitro. There is substantial variability in nickel elution; the safety of low nickel elution devices in patients with nickel allergy needs to...
We sought to compare nickel elution properties of contemporary interatrial shunt closure devices in vitro. There is substantial variability in nickel elution; the safety of low nickel elution devices in patients with nickel allergy needs to...
We sought to compare nickel...
02/01/2015
Journal of Invasive Cardiology
Original Contribution
02/01/2015

Christian Jung, MD1;  Marcus Franz, MD1;  Hans-Rainer Figulla, MD1;  Steffen Sonntag, MD2;  Martin Hug, MD3

Harald Mudra, MD3;  Robert Bauerschmitt, MD4;  Franz-Xaver Kleber, MD5;  Peter Feindt, MD6

Uwe Mehlhorn, MD7;  Christian Vahl, MD7;  Hans-Juergen Bruns, PhD8;  Markus Ferrari, MD9

 
Christian Jung, MD1;  Marcus Franz, M...
Mortality rates remain high in patients with cardiogenic shock or acute refractory circulatory failure. This study evaluates the procedural performance and safety of the automated Lifebridge extracorporeal life support system (Zoll Lifebridge...
Mortality rates remain high in patients with cardiogenic shock or acute refractory circulatory failure. This study evaluates the procedural performance and safety of the automated Lifebridge extracorporeal life support system (Zoll Lifebridge...
Mortality rates remain high in...
02/01/2015
Journal of Invasive Cardiology
Original Contribution
02/01/2015

Lorenzo Azzalini, MD, MSc and Philippe L. L’Allier, MD

 
Lorenzo Azzalini, MD, MSc and Philipp...
Experience with bioresorbable vascular scaffolds (BVSs) outside clinical trials is scarce, and data from “real-world” use are needed. In particular, there are few data on scaffold thrombosis (ST); we report our experience with ST in our...
Experience with bioresorbable vascular scaffolds (BVSs) outside clinical trials is scarce, and data from “real-world” use are needed. In particular, there are few data on scaffold thrombosis (ST); we report our experience with ST in our...
Experience with bioresorbable...
02/01/2015
Journal of Invasive Cardiology
Original Contribution
02/01/2015

Siddharth M. Patel, BS;  Nagendra R. Pokala, BS;  Rohan V. Menon, BS;  Anna P. Kotsia, MD;  Vijay Raja, MD; 

George Christopoulos, MD;  Tesfaldet T. Michael, MD, MPH;  Bavana V. Rangan, BDS, MPH;  Daniel Sherbet, MD; 

Vishal G. Patel, MD;  Shuaib A. Abdullah, MD;  Jeffrey Hastings, MD;  Jerrold M. Grodin, MD; 

Subhash Banerjee, MD;  Emmanouil S. Brilakis, MD, PhD

Siddharth M. Patel, BS;  Nagendra R. ...
We retrospectively examined 373 consecutive CTO-PCIs performed at our institution between 2005 and 2013 to determine the frequency and treatment of balloon-uncrossable CTOs. Balloon-uncrossable CTOs are encountered in 6.4% of contemporary...
We retrospectively examined 373 consecutive CTO-PCIs performed at our institution between 2005 and 2013 to determine the frequency and treatment of balloon-uncrossable CTOs. Balloon-uncrossable CTOs are encountered in 6.4% of contemporary...
We retrospectively examined 373...
02/01/2015
Journal of Invasive Cardiology
Original Contribution
02/01/2015

Nevio Taglieri, MD;  Gabriele Ghetti, MD;  Francesco Saia, MD, PhD;  Carolina Moretti, MD;  Pamela Gallo, MD;  

Gianni Dall‚ÄôAra;  Tullio Palmerini, MD;  Cinzia Marrozzini, MD;  Claudio Rapezzi, MD;  Antonio Marzocchi, MD

Nevio Taglieri, MD;  Gabriele Ghetti,...
Incomplete stent strut coverage is a risk factor for late stent thrombosis. This study evaluates strut coverage after biolimus-A9 eluting stent (BES) implantation for unprotected left main artery (ULMA) stenosis during follow-up and identify...
Incomplete stent strut coverage is a risk factor for late stent thrombosis. This study evaluates strut coverage after biolimus-A9 eluting stent (BES) implantation for unprotected left main artery (ULMA) stenosis during follow-up and identify...
Incomplete stent strut coverage...
02/01/2015
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement